Ngā hua rapu - Anuradha Chakravarthy
- E whakaatu ana i te 1 - 3 hua o te 3
-
1
Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer mā Emily Chan, Lori R. Arlinghaus, Dana B. Cardin, Laura W. Goff, Jordan Berlin, Alexander A. Parikh, Richard G. Abramson, Thomas E. Yankeelov, Scott W. Hiebert, Nipun B. Merchant, Srividya Bhaskara, Anuradha Chakravarthy
I whakaputaina 2016Artigo -
2
Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results mā Thomas E. Yankeelov, Martin Lepage, Anuradha Chakravarthy, Elizabeth E. Broome, Kenneth J. Niermann, Mark C. Kelley, Ingrid M. Meszoely, Ingrid A. Mayer, Cheryl R. Herman, Kevin McManus, Ronald R. Price, John C. Gore
I whakaputaina 2006Artigo -
3
Multiparametric Magnetic Resonance Imaging for Predicting Pathological Response After the First Cycle of Neoadjuvant Chemotherapy in Breast Cancer mā Xia Li, Richard G. Abramson, Lori R. Arlinghaus, Hakmook Kang, Anuradha Chakravarthy, Vandana G. Abramson, Jaime Farley, Ingrid A. Mayer, Mark C. Kelley, Ingrid M. Meszoely, Julie Means‐Powell, Ana M. Grau, Melinda E. Sanders, Thomas E. Yankeelov
I whakaputaina 2014Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Cancer
Internal medicine
Medicine
Breast cancer
Chemotherapy
Magnetic resonance imaging
Nuclear medicine
Oncology
Radiology
Adverse effect
Biochemistry
Capecitabine
Chemistry
Colorectal cancer
Complete response
Diffusion MRI
Dynamic contrast
Dynamic contrast-enhanced MRI
Effective diffusion coefficient
Gastroenterology
Gene
Histone
Histone deacetylase
Nausea
Neoadjuvant therapy
Nuclear magnetic resonance
Pancreatic cancer
Pathological
Phases of clinical research
Physics